Status:
RECRUITING
Cardiopulmonary Adaptations to High-intensity Interval Training (HIIT) in COPD
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
COPD
Rehabilitation
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The aim of this prospective randomised controlled trial in which the impact of high intensity interval training (HIIT) on pulmonay blood volume, pulmonary gas exchange during exercise, and lung tissue...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Men and women
- Age \>=40 and \<80 years
- COPD (GOLD stage I to III)
- Modified Medical Research Council score (mMRC) of 0 to 3
- Resting arterial oxygenation \> 90% Exclusion criteria
- Symptoms of ischaemic heart disease
- Known heart failure
- Unable to complete or understand HIIT training
- Claudication
- Symptoms of disease within 2 weeks prior to the study
- Participation in pulmonary rehabilitation within 3 months
- Known malignant disease
- Pregnancy
- Unstable cardiac arrhythmic disease
- Renal or liver dysfunction
- Known chronic kidney or liver disease
- Elevated creatinine, urea, alanine transaminase (ALAT), aspartate transaminase (ASAT), bilirubin, basic phosphatases at blood test
- Completion of pulmonary rehabilitation within the last 3 months
Exclusion
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06551441
Start Date
August 1 2024
End Date
August 1 2026
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center For Physical Activity Research, Rigshospitalet
Copenhagen, Denmark